These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21793786)

  • 1. Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting.
    Lévesque MV; Rouleau SG; Perreault JP
    Nucleic Acid Ther; 2011 Aug; 21(4):241-52. PubMed ID: 21793786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
    Lainé S; Scarborough RJ; Lévesque D; Didierlaurent L; Soye KJ; Mougel M; Perreault JP; Gatignol A
    RNA Biol; 2011; 8(2):343-53. PubMed ID: 21422817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating a new generation of ribozymes in order to target HCV.
    Lévesque MV; Lévesque D; Brière FP; Perreault JP
    PLoS One; 2010 Mar; 5(3):e9627. PubMed ID: 20224783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme.
    Asif-Ullah M; Lévesque M; Robichaud G; Perreault JP
    Curr Gene Ther; 2007 Jun; 7(3):205-16. PubMed ID: 17584038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.
    Jeng KS; Daniel A; Lai MM
    J Virol; 1996 Apr; 70(4):2403-10. PubMed ID: 8642668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the trans Watson-Crick GU base pair located in the catalytic core of the antigenomic HDV ribozyme.
    Lévesque D; Reymond C; Perreault JP
    PLoS One; 2012; 7(6):e40309. PubMed ID: 22768274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of HDV ribozymes to trans-cleave HCV RNA.
    Yu YC; Mao Q; Gu CH; Li QF; Wang YM
    World J Gastroenterol; 2002 Aug; 8(4):694-8. PubMed ID: 12174380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-distance communication in the HDV ribozyme: insights from molecular dynamics and experiments.
    Veeraraghavan N; Bevilacqua PC; Hammes-Schiffer S
    J Mol Biol; 2010 Sep; 402(1):278-91. PubMed ID: 20643139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of an extra substrate binding site and partial destabilization of stem structures in HDV ribozyme give rise to high sequence-specificity for its target RNA.
    Hori T; Guo F; Uesugi S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):489-501. PubMed ID: 16838841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An AU at the first base pair of helix 3 elevates the catalytic activity of hepatitis delta virus ribozymes.
    Huang ZS; Ping YH; Wu HN
    FEBS Lett; 1997 Aug; 413(2):299-303. PubMed ID: 9280301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct catalytic strategies in the hepatitis δ virus ribozyme cleavage reaction.
    Golden BL
    Biochemistry; 2011 Nov; 50(44):9424-33. PubMed ID: 22003985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the SOFA delta ribozyme.
    Bergeron LJ; Reymond C; Perreault JP
    RNA; 2005 Dec; 11(12):1858-68. PubMed ID: 16251383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape.
    Sripathi KN; Tay WW; Banáš P; Otyepka M; Šponer J; Walter NG
    RNA; 2014 Jul; 20(7):1112-28. PubMed ID: 24854621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.